Coherus Biosciences Inc (OQ:CHRS)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for CHRS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 19th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 17/20 Jan 15/20 Viret Jean-Frederic Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -6,318  
Jan 17/20 Jan 15/20 Viret Jean-Frederic Direct Ownership Common Stock, $0.0001 par value S - Open market or private sale -2,798 $20.08
Jan 17/20 Jan 15/20 Viret Jean-Frederic Direct Ownership Common Stock, $0.0001 par value S - Open market or private sale -3,520 $19.67
Jan 17/20 Jan 15/20 Viret Jean-Frederic Direct Ownership Common Stock, $0.0001 par value M - Exercise or conversion exempt under rule 16b-3 6,318 $10.05
Jan 13/20 Jan 12/20 Healy James Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -20,000  
Jan 13/20 Jan 12/20 Healy James Direct Ownership Common Stock, $0.0001 par value M - Exercise or conversion exempt under rule 16b-3 20,000 $12.37
Jan 14/20 Jan 10/20 Satvat Ali J. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 10/20 Szela Mary T Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 10/20 Wahlstrom Mats Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 10/20 Healy James Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CHRS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 19th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 17/20 Jan 15/20 Viret Jean-Frederic Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -6,318  
Jan 17/20 Jan 15/20 Viret Jean-Frederic Direct Ownership Common Stock, $0.0001 par value S - Open market or private sale -2,798 $20.08
Jan 17/20 Jan 15/20 Viret Jean-Frederic Direct Ownership Common Stock, $0.0001 par value S - Open market or private sale -3,520 $19.67
Jan 17/20 Jan 15/20 Viret Jean-Frederic Direct Ownership Common Stock, $0.0001 par value M - Exercise or conversion exempt under rule 16b-3 6,318 $10.05
Jan 14/20 Jan 10/20 Satvat Ali J. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 10/20 Szela Mary T Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 10/20 Wahlstrom Mats Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 10/20 Healy James Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 10/20 Lawlis V Bryan Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Jan 14/20 Jan 10/20 Richards Christos Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 20,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CHRS